Answers are grounded in this paper and cite their sources.
The fibroblast growth factors (FGFs) are a family of homologous protein mitogens composed of nine known members that selectively function through at least four high affinity membrane spanning tyrosine kinase receptors. Most, if not all, of the FGF family homologues bind avidly to heparin and heparan proteoglycans which could not only stabilize and localize these proteins but also directly participate in the complexation of FGFs with their high affinity receptors. The two originally identified and currently most thoroughly characterized members of the FGF family are commonly denoted acidic and basic FGF, or simply aFGF and bFGF. Both of these proteins are mitogenic for a wide variety of cells of mesodermal and ectodermal embryonic origin and are neurotrophic for various types of central and peripheral neurons. They have also been shown in several cellular systems to support chemotactic migration and induction of proteases that could facilitate tissue remodeling. For example, the promotion of vascular endothelial cell protease expression, chemotactic migration and proliferation in vitro presumably contribute to their observed ability to induce blood vessel growth, or angiogenesis, in vivo . This angiogenic activity coupled with the broad target cell spectrum, receptor induction by tissue damage and localization by heparan proteoglycan binding contribute to the therapeutic potential of these endogenous proteins as safe and efficacious drugs to promote repair of a variety of acutely and chronically damaged tissues.
No takes yet. Share an insight, caveat, or question.
Middaugh et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: